| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 6305 | 2008 |
| Cost of disorders of the brain in Europe 2010 A Gustavsson, M Svensson, F Jacobi, C Allgulander, J Alonso, E Beghi, ... European neuropsychopharmacology 21 (10), 718-779, 2011 | 2261 | 2011 |
| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement disorders 32 (6), 853-864, 2017 | 1672 | 2017 |
| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan CG Goetz, S Fahn, P Martinez‐Martin, W Poewe, C Sampaio, GT Stebbins, ... Movement disorders 22 (1), 41-47, 2007 | 1505 | 2007 |
| Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition KR Bales, T Verina, RC Dodel, Y Du, L Altstiel, M Bender, P Hyslop, ... Nature genetics 17 (3), 263-264, 1997 | 1079 | 1997 |
| Prevalence and incidence of Parkinson's disease in Europe S Von Campenhausen, B Bornschein, R Wick, K Bötzel, C Sampaio, ... European neuropsychopharmacology 15 (4), 473-490, 2005 | 978 | 2005 |
| Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease Y Du, Z Ma, S Lin, RC Dodel, F Gao, KR Bales, LC Triarhou, E Chernet, ... Proceedings of the National Academy of Sciences 98 (25), 14669-14674, 2001 | 957 | 2001 |
| Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease KR Bales, T Verina, DJ Cummins, Y Du, RC Dodel, J Saura, CE Fishman, ... Proceedings of the National Academy of Sciences 96 (26), 15233-15238, 1999 | 636 | 1999 |
| The natural history of multiple system atrophy: a prospective European cohort study GK Wenning, F Geser, F Krismer, K Seppi, S Duerr, S Boesch, ... The lancet neurology 12 (3), 264-274, 2013 | 545 | 2013 |
| Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease RC Dodel, Y Du, C Depboylu, H Hampel, L Frölich, A Haag, U Hemmeter, ... Journal of Neurology, Neurosurgery & Psychiatry 75 (10), 1472-1474, 2004 | 444 | 2004 |
| Long-term outcome after stroke: evaluating health-related quality of life using utility measurements C Haacke, A Althaus, A Spottke, U Siebert, T Back, R Dodel Stroke 37 (1), 193-198, 2006 | 417 | 2006 |
| Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment H Hampel, SJ Teipel, T Fuchsberger, N Andreasen, J Wiltfang, M Otto, ... Molecular psychiatry 9 (7), 705-710, 2004 | 415 | 2004 |
| Cognitive impairment in 873 patients with idiopathic Parkinson's disease: results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD) O Riedel, J Klotsche, A Spottke, G Deuschl, H Förstl, F Henn, I Heuser, ... Journal of neurology 255, 255-264, 2008 | 377 | 2008 |
| Reduced levels of amyloid β-peptide antibody in Alzheimer disease Y Du, R Dodel, H Hampel, K Buerger, S Lin, B Eastwood, K Bales, F Gao, ... Neurology 57 (5), 801-805, 2001 | 353 | 2001 |
| Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons Y Du, KR Bales, RC Dodel, E Hamilton-Byrd, JW Horn, DL Czilli, ... Proceedings of the National Academy of Sciences 94 (21), 11657-11662, 1997 | 352 | 1997 |
| The future of Alzheimer's disease: the next 10 years H Hampel, D Prvulovic, S Teipel, F Jessen, C Luckhaus, L Frölich, ... Progress in neurobiology 95 (4), 718-728, 2011 | 332 | 2011 |
| Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease O Riedel, J Klotsche, A Spottke, G Deuschl, H Förstl, F Henn, I Heuser, ... Journal of neurology 257, 1073-1082, 2010 | 301 | 2010 |
| Association of an interleukin 1α polymorphism with Alzheimer’s disease Y Du, RC Dodel, BJ Eastwood, KR Bales, F Gao, F Lohmuller, U Muller, ... Neurology 55 (4), 480-484, 2000 | 287 | 2000 |
| Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument E Kalbe, P Calabrese, N Kohn, R Hilker, O Riedel, HU Wittchen, R Dodel, ... Parkinsonism & related disorders 14 (2), 93-101, 2008 | 286 | 2008 |
| IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats X Wei, Z Du, L Zhao, D Feng, G Wei, Y He, J Tan, WH Lee, H Hampel, ... Stem cells 27 (2), 478-488, 2009 | 284 | 2009 |
